David Berz, Daniel Morgensztern, Rachel E. Sanborn, Thomas Stewart Atkinson, Robert M. Jotte, Kartik Konduri, Donald A. Richards, Alexander I. Spira, Mark S. Berger. "Predictive biomarkers for PFS in patients receiving quaratusugene ozeplasmid.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15184